Vasopressin in sodium chloride injection is generally used to increase blood pressure when other measures have failed for patients in critical hypotensive shock.
Topiramate extended-release capsules are indicated for the treatment of partial-onset or primary generalized tonic-clonic seizures in certain patients.
As of June 2024, the FDA has approved a total of 57 biosimilars across 17 unique biological molecules; of the 57 approvals, 39 biosimilars have launched in the U.S. market.